Krempa David 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Krempa David（CIK 1968254）在 1 家公司共报告 20 笔 SEC Form 4 内部人交易（最近一笔 2026-10-06）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-06 | Eton Pharmaceuticals, Inc. (ETON) | Chief Business Officer | 买入 | 10,522 | $0 |
| 2026-10-06 | Eton Pharmaceuticals, Inc. (ETON) | Chief Business Officer | 卖出 | 4,166 | $229,406 |
| 2026-08-24 | Eton Pharmaceuticals, Inc. (ETON) | Chief Business Officer | 买入 | 25,000 | $182,750 |
| 2026-08-24 | Eton Pharmaceuticals, Inc. (ETON) | Chief Business Officer | 卖出 | 25,000 | $1.6M |
| 2026-07-13 | Eton Pharmaceuticals, Inc. (ETON) | Chief Business Officer | 买入 | 10,000 | $0 |
| 2026-05-27 | Eton Pharmaceuticals, Inc. (ETON) | Chief Business Officer | 买入 | 30,591 | $109,516 |
| 2026-05-27 | Eton Pharmaceuticals, Inc. (ETON) | Chief Business Officer | 卖出 | 32,963 | $1.1M |
| 2026-05-27 | Eton Pharmaceuticals, Inc. (ETON) | Chief Business Officer | 卖出 | 9,315 | $315,592 |
| 2026-05-27 | Eton Pharmaceuticals, Inc. (ETON) | Chief Business Officer | 卖出 | 519 | $18,165 |
| 2026-05-27 | Eton Pharmaceuticals, Inc. (ETON) | Chief Business Officer | 买入 | 25,000 | $34,500 |
| 2026-05-27 | Eton Pharmaceuticals, Inc. (ETON) | Chief Business Officer | 买入 | 12,524 | $17,158 |
| 2026-05-27 | Eton Pharmaceuticals, Inc. (ETON) | Chief Business Officer | 卖出 | 37,524 | $1.2M |
| 2026-05-27 | Eton Pharmaceuticals, Inc. (ETON) | Chief Business Officer | 买入 | 12,476 | $17,092 |
| 2026-05-27 | Eton Pharmaceuticals, Inc. (ETON) | Chief Business Officer | 买入 | 7,203 | $25,787 |
| 2026-05-27 | Eton Pharmaceuticals, Inc. (ETON) | Chief Business Officer | 卖出 | 19,679 | $619,298 |
| 2026-01-14 | Eton Pharmaceuticals, Inc. (ETON) | Chief Business Officer | 卖出 | 1,942 | $30,334 |
| 2025-12-12 | Eton Pharmaceuticals, Inc. (ETON) | Chief Business Officer | 卖出 | 6,264 | $106,488 |
| 2025-06-16 | Eton Pharmaceuticals, Inc. (ETON) | Chief Business Officer | 卖出 | 16,977 | $253,297 |
| 2025-06-16 | Eton Pharmaceuticals, Inc. (ETON) | Chief Business Officer | 卖出 | 6,800 | $100,436 |
| 2025-06-16 | Eton Pharmaceuticals, Inc. (ETON) | Chief Business Officer | 卖出 | 10,223 | $150,585 |
来源：SEC Form 4 申报文件 · 截至 2026-10-06